Harvard Bioscience, Inc. (NASDAQ:HBIO) Shares Sold by Legato Capital Management LLC

Legato Capital Management LLC reduced its stake in shares of Harvard Bioscience, Inc. (NASDAQ:HBIO) by 59.7% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 14,695 shares of the medical instruments supplier’s stock after selling 21,730 shares during the period. Legato Capital Management LLC’s holdings in Harvard Bioscience were worth $31,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. GSA Capital Partners LLP acquired a new stake in Harvard Bioscience during the 3rd quarter worth about $30,000. SG Americas Securities LLC acquired a new stake in Harvard Bioscience during the 3rd quarter worth about $36,000. Avior Wealth Management LLC grew its position in Harvard Bioscience by 1,118.1% during the 3rd quarter. Avior Wealth Management LLC now owns 14,569 shares of the medical instruments supplier’s stock worth $39,000 after purchasing an additional 13,373 shares during the period. Landscape Capital Management L.L.C. acquired a new stake in Harvard Bioscience during the 3rd quarter worth about $50,000. Finally, Corsair Capital Management L.P. acquired a new stake in shares of Harvard Bioscience during the 3rd quarter valued at about $63,000. 80.87% of the stock is owned by institutional investors and hedge funds.

Harvard Bioscience Price Performance

NASDAQ:HBIO opened at $1.35 on Friday. Harvard Bioscience, Inc. has a 52 week low of $1.26 and a 52 week high of $4.91. The company has a quick ratio of 0.91, a current ratio of 2.06 and a debt-to-equity ratio of 0.52. The stock has a market capitalization of $58.88 million, a PE ratio of -4.09 and a beta of 1.25. The stock’s 50-day moving average price is $1.94 and its 200-day moving average price is $2.37.

Harvard Bioscience Profile

Harvard Bioscience, Inc develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings.